렌즈 테라퓨틱스(LENZ)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $4.10 (-0.73%), 시가총액 $0.23B, 52주 최저~최고 $7.29 ~ $49.05.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
렌즈 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
렌즈 테라퓨틱스의 현재 주가는 $4.10 (-0.73%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
렌즈 테라퓨틱스의 시가총액은 약 $0.23B입니다.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidate